Metabolic and genetic risk factors for migraine in children

Cephalalgia

Volumn 26, Issue 6, 2006, Pages 731-737

  Bottini, F ^b   Celle, M E ^a   Calevo, M G ^b   Amato, S ^b   Minniti, G ^a   Montaldi, L ^a   Di Pasquale, D ^a   Cerone, R ^a   Veneselli, E ^a   Molinari, A C ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Childhood; Folate metabolism; Migraine; Prothrombotic conditions; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PROTHROMBIN;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; CHEMICAL ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; MIGRAINE; MUTANT; MUTATIONAL ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; ITALY; MALE; METABOLIC DISEASES; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; MUTATION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 33745219611     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01107.x     Document Type: Article

References (32)

1. Merikangas KR, Febton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997 54 : 362 8.
2. Bassi B, Parodi E, Messina M, Boffi P, Campagnoli MF, Rigardetto R, Saracco P. Screening for genetic and acquired thrombophilia in a cohort of young migrainous patients. J Headache Pain 2003 4 : 138 45.
3. Narbone MC, Leggiadro N, La Spina P, Rao R, Grugno R, Musolino R. Migraine and stroke: a possible complication of both migraine with and without aura. Headache 1996 36 : 481 3.
4. Henrich JB, Sandercock PA, Warlow CP, Jones LN. Stroke and migraine in the Oxfordshire Community Stroke Project. J Neurol 1986 233 : 257 62.
5. Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004 24 ( Suppl. 1 32 3.
6. Ebinger F, Boor R, Gawehn J, Reitter B. Ischemic stroke and migraine in childhood: coincidence or causal relation?. J Child Neurol 1999 14 : 451 5.
7. Rossi LN. Relationship between migraine and stroke in paediatric age. J Headache Pain 2004 5 : 56.
8. Welch KM, Levine SR. Migraine related stroke in the context of the International Headache Society Classification of Head Pain. Arch Neurol 1990 47 : 458 62.
9. Kovacs K, Herman F, Filep J, Jelencsik I, Magyar K, Csanda E. Platelet aggregation of migraneurs during and between attacks. Cephalalgia 1990 10 : 161 5.
10. Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR, Levine SR. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events. A prospective study. Neurology 1998 50 : 1433 40.
11. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995 73 : 558 60.
12. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M et al. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998 91 : 3562 5.
13. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000 96 : 762 4.
14. Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2004 2 : 3.
15. Oterino A, Valle N, Bravo Y, Munoz P, Sanchez-Velasco P, Ruiz-Alegria C et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 2004 24 : 491 4.
16. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003 53 : 167 73.
17. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003 111 : 84 0.
18. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005 330 : 345.
19. Headache Classification Committee of the International Headache Society. Diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 ( Suppl. 7 20.
20. Gallai V, Sarchielli P, Carboni F, Benedetti P, Mastropaolo C, Puca F. Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Juvenile Headache Collaborative Study Group. Headache 1995 35 : 146 53.
21. Cano A, Palomeras E, Alfonso S, Ortega D, Sanz P, Fossas P. Migraine without aura and migrainous disorder in children; International Headache Society (IHS) and revised IHS criteria. Cephalalgia 2000 20 : 617 20.
22. Rossi LN, Cortinovis I, Menegazzo L, Brunelli G, Bossi A, Macchi M. Classification criteria and distinction between migraine and tension-type headache in children. Dev Med Child Neurol 2001 43 : 45 1.
23. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995 10 : 111 3.
24. Van der Put NM, Blom HJ. Reply to Donnelly. Am J Hum Genet 2000 66 : 744 5 (Letter to Editor).
25. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 88 : 3698 03.
26. Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B et al. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in Factor V in 113 unrelated symptomatic protein C deficient patients. The French Network on the behalf of INSERM. Blood 1995 86 : 219 24.
27. Minniti G, Piana A, Armani U, Cerone R. Determination of plasma and serum homocysteine by high-performance liquid chromatography with fluorescence detection. J Chromatogr A 1998 828 : 401 5.
28. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002 47 : 319 24.
29. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998 64 : 169 72.
30. Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK. Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 1999 86 : 380 4.
31. Corral J, Iniesta JA, Gonzales-Conejero R, Lonzano ML, Rivera J, Vincente V. Migraine and prothrombotic genetic risk factors. Cephalalgia 1998 18 : 257 60.
32. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998 38 : 779 81.